Bestidine Tablet 40 mg (Famotidine)

Adult dosage

1. Gastric and duodenal ulcers, junctional ulcers, upper gastrointestinal bleeding, gastroesophageal reflux disease, Zollinger-Ellison syndrome: Administer Famotidine 20 mg orally twice a day (after breakfast, after dinner, or at bedtime) or 40 mg once a day (at bedtime). For upper gastrointestinal bleeding, start treatment with injection and switch to oral administration afterward. 2. Improvement of gastric mucosal lesions (acute gastritis, acute exacerbation of chronic gastritis): Famotidine 20 mg.

This drug should not be used in patients who are allergic to its components or who have a genetic problem of lactose intolerance. Caution should be exercised when using this drug in patients with drug allergies or problems with the kidneys, liver, or heart, as well as in the elderly. Serious side effects such as shock, blood disorders, skin diseases, liver dysfunction, muscle problems, heart rhythm abnormalities, consciousness disorders, kidney problems, and pneumonia may occur during the use of this drug, so symptoms should be closely monitored. If side effects are suspected, medication should be discontinued immediately, and medical treatment should be sought. Generally, this drug should be used at the minimum dosage that still provides a therapeutic effect, and if ineffective, alternative treatments should be considered. It is important to have regular blood tests and liver and kidney function tests to monitor the condition. Patients undergoing dialysis should be cautious when taking this drug with certain phosphate binders, as it may reduce effectiveness. There may be drug interactions, so consult a physician especially when taking antifungal medications or certain anticancer drugs. Elderly patients may have increased drug concentration in their bodies due to reduced kidney function, so dosage adjustments may be necessary. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this drug, and breastfeeding women should discontinue breastfeeding as the drug can be transmitted through breast milk. The safety of this drug in children has not been sufficiently established, so caution is needed for its use. This drug may obscure the symptoms of gastric cancer, so it should not be used until gastric cancer has been ruled out.

Serious side effects

Shock, hypersensitivity (anaphylaxis, respiratory distress, generalized flushing, angioedema, urticaria), pancytopenia, agranulocytosis, aplastic anemia, hemolytic anemia, thrombocytopenia, Stevens-Johnson syndrome, Lyell's syndrome, liver dysfunction, jaundice, rhabdomyolysis, QT prolongation, ventricular tachycardia, ventricular fibrillation, altered consciousness, seizures, interstitial nephritis, acute renal failure, interstitial pneumonia, congestive heart failure

Mild side effects

• Rash
• urticaria (erythema)
• facial swelling
• leukopenia
• thrombocytopenia
• eosinophilia
• constipation
• diarrhea
• dark stools
• dry mouth

This drug should be stored in a tightly closed container to prevent exposure to air or moisture. The recommended storage temperature is between 1 degree and 30 degrees Celsius at room temperature.

Appearance

Green round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle